Daniele Bolognini

Author PubWeight™ 8.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity. Mol Pharmacol 2012 1.26
2 Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist. Eur J Pharmacol 2010 0.98
3 Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators. J Biol Chem 2007 0.87
4 Expression and function of the endocannabinoid system in glial cells. Curr Pharm Des 2008 0.80
5 Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands. J Med Chem 2010 0.79
6 Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect. PLoS One 2013 0.79
7 Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach. ChemMedChem 2012 0.77
8 In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists. Pharmacol Res 2009 0.77
9 Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors. Eur J Med Chem 2012 0.76
10 Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates. BMC Neurosci 2010 0.76